Koios Beverage is set to expand its portfolio with the launch of two additional drinks in October this year.

The first of the two products will be infused with cannabidiol (CBD), a cannabinoid that is derived from hemp plants. CBD is commonly used to address inflammation, pain, anxiety and epileptic seizures.

The beverage will also contain nootropic supplements, which are used to enhance productivity.

CEO and director Chris Miller said: “We are just scratching the surface of what cannabinoids like CBD can do for human health. CBD is the best researched of all the cannabinoids within the cannabis plant and is well known for its restorative effect on human health, and in dealing with various types of pain.

“We are just scratching the surface of what cannabinoids like CBD can do for human health.”

“With our focus on creating optimal human performance and health through our natural supplements, a CBD-infused beverage was a natural next step.

“A CBD infused beverage will be a tremendous value to the market and will allow us to come one step closer to realising our vision of helping a billion people live healthier lives.”

Koios plans to launch the second of its new beverages through its Cannavated subsidiary, as well as in collaboration with its partner Keef Brands, a division of CanCore Concepts.

Keef Brands will responsible for manufacturing, marketing and selling the beverage line-up, which is infused with tetrahydrocannabinol (THC) and nootropic supplements from the Koios line of functional beverages.

Koios Beverage claims that its products have the ability to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and mental clarity.